注射吸毒者中的念珠菌血流感染——科罗拉多州丹佛大都会区,2017—2018年
22名患者中7例(32%)为播散性念珠菌病伴终末器官功能障碍,4例(18%)住院期间死亡。
要点
- 念珠菌血症前一年内有注射吸毒史者占203例中的23例(11%)。
- 22名患者中7例(32%)为播散性念珠菌病伴终末器官功能障碍,4例(18%)住院期间死亡。
核心结论
- 注射吸毒是念珠菌血症的相关危险因素,且可在医院和社区环境中发挥作用。
- 除社区干预外,在医疗接触期间干预以减少注射吸毒和不安全注射行为,可能预防注射吸毒者的念珠菌血症等感染。
研究设计与样本
- 监测期间为2017年5月至2018年8月,收集念珠菌血培养阳性者的 demographic、临床和注射吸毒行为信息。
主要发现
- 203例念珠菌血症中,23例(11%)发生于念珠菌血症前一年内有注射吸毒史的22名患者。
- 22名患者中7例(32%)有播散性念珠菌病伴终末器官功能障碍,4例(18%)住院期间死亡。
- 六名(27%)患者报告住院期间注射吸毒。
临床怎么用
- 在医疗接触期间识别注射吸毒行为,并干预以减少注射吸毒和不安全注射行为,可能预防念珠菌血症等感染。
- 对注射吸毒者需同时关注社区和医院环境中的感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Candidemia, a bloodstream infection caused by Candida species, is typically considered a health care-associated infection, with known risk factors including the presence of a central venous catheter, receipt of total parenteral nutrition or broad-spectrum antibiotics, recent abdominal surgery, admission to an intensive care unit, and prolonged hospitalization (1,2). Injection drug use (IDU) is not a common risk factor for candidemia; however, in the context of the ongoing opioid epidemic and corresponding IDU increases, IDU has been reported as an increasingly common condition associated with candidemia (3) and methicillin-resistant Staphylococcus aureus bacteremia (4). Little is known about the epidemiology of candidemia among persons who inject drugs. The Colorado Department of Public Health and Environment (CDPHE) conducts population-based surveillance for candidemia in the five-county Denver metropolitan area, encompassing 2.7 million persons, through CDC's Emerging Infections Program (EIP). As part of candidemia surveillance, CDPHE collected demographic, clinical, and IDU behavior information for persons with Candida-positive blood cultures during May 2017-August 2018. Among 203 candidemia cases reported, 23 (11%) occurred in 22 patients with a history of IDU in the year preceding their candidemia episode. Ten (43%) of the 23 cases were considered community-onset infections, and four (17%) cases were considered community-onset infections with recent health care exposures. Seven (32%) of the 22 patients had disseminated candidiasis with end-organ dysfunctions; four (18%) died during their hospitalization. In-hospital IDU was reported among six (27%) patients, revealing that IDU can be a risk factor in the hospital setting as well as in the community. In addition to community interventions, opportunities to intervene during health care encounters to decrease IDU and unsafe injection practices might prevent infections, including candidemia, among persons who inject drugs.
引用
- Barter DM, Johnston HL, Williams SR, et al. Candida Bloodstream Infections Among Persons Who Inject Drugs - Denver Metropolitan Area, Colorado, 2017-2018. MMWR Morb Mortal Wkly Rep. 2019. PMID: 30921302. doi:10.15585/mmwr.mm6812a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。